Alphavirus M1 induces apoptosis of malignant glioma cells via downregulation and nucleolar translocation of p21WAF1/CIP1 protein

Cell Cycle

Volumn 8, Issue 20, 2009, Pages 3328-3339

  Hu, Jun ^a   Cai, Xiao Feng ^a   Yan, Guangmei ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Alphavirus; Apoptosis; Caspase; CDK2; NPM; Nucleolar translocation; p21; S phase

Indexed keywords

CASPASE 3; CELL CYCLE PROTEIN; CYCLIN A; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 2 INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLINE; LACTATE DEHYDROGENASE; NUCLEOPHOSMIN; PROCASPASE 3; PROTEIN BAX; PROTEIN BCL 2; ROSCOVITINE;

ALPHA VIRUS; ALPHA VIRUS M1; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE S PHASE; CELL SURVIVAL; CONFOCAL MICROSCOPY; DOWN REGULATION; FLOW CYTOMETRY; GLIOBLASTOMA; GLIOMA CELL; NONHUMAN; NUCLEOLUS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; TARGET CELL; VIRUS ISOLATION;

ALPHAVIRUS; ARTHROPODA; TOGAVIRIDAE;

EID: 70350217760     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.8.20.9832     Document Type: Article

References (79)

1. Huang Q, Pu P, Xia Z, You Y. Exogenous wt-p53 enhances the antitumor effect of HSV-TK/GCV on C6 glioma cells. J Neurooncol 2007; 82:239-248 (Pubitemid 46614385)
2. Ruan S, Okcu MF, Pong RC, Andreeff M, Levin V, Hsieh JT, et al. Attenuation of WAF1/Cip1 expression by an antisense adenovirus expression vector sensitizes glioblastoma cells to apoptosis induced by chemotherapeutic agents 1,3-bis(2-chloroethyl)-1-nitrosourea and cisplatin. Clin Cancer Res 1999; 5:197-202. (Pubitemid 29045194)
3. Xu GW, Nutt CL, Zlatescu MC, Keeney M, Chin-Yee I, Cairncross JG. Inactivation of p53 sensitizes U87MG glioma cells to 1,3-bis(2-chloroethyl)-1- nitrosourea. Cancer Res 2001; 61:4155-4159 (Pubitemid 32720984)
4. Besson A, Yong VW. Involvement of p21(Waf1/Cip1) in protein kinase C alpha-induced cell cycle progression. Mol Cell Biol 2000; 20:4580-4590 (Pubitemid 30396106)
5. Dotto GP. p21(WAF1/Cip1): more than a break to the cell cycle? Biochim Biophys Acta 2000; 1471:43-56.
6. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006; 444:756-760 (Pubitemid 44949604)
7. Li Y, Yin W, Wang X, Zhu W, Huang Y, Yan G. Cholera toxin induces malignant glioma cell differentiation via the PKA/CREB pathway. Proc Natl Acad Sci USA 2007; 104:13438-13443 (Pubitemid 47293963)
8. Pulkkanen KJ, Yla-Herttuala S. Gene therapy for malignant glioma: current clinical status. Mol Ther 2005; 12:585-598 (Pubitemid 41350140)
9. Wang KS, Kuhn RJ, Strauss EG, Ou S, Strauss JH. High-affinity laminin receptor is a receptor for Sindbis virus in mammalian cells. J Virol 1992; 66:4992-5001.
10. Tseng JC, Levin B, Hurtado A, Yee H, Perez de Castro I, Jimenez M, et al. Systemic tumor targeting and killing by Sindbis viral vectors. Nat Biotechnol 2004; 22:70-77 (Pubitemid 38057959)
11. Zhang J, Frolov I, Russell SJ. Gene therapy for malignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein. J Gene Med 2004; 6:1082-1091 (Pubitemid 40228121)
12. Ren H, Boulikas T, Lundstrom K, Soling A, Warnke PC, Rainov NG. Immunogene therapy of recurrent glioblastoma multiforme with a liposomally encapsulated replication-incompetent Semliki forest virus vector carrying the human interleukin-12 gene - a phase I/ II clinical protocol. J Neurooncol 2003; 64:147-154 (Pubitemid 36992469)
13. Scallan MF, Allsopp TE, Fazakerley JK. bcl-2 acts early to restrict Semliki Forest virus replication and delays virus-induced programmed cell death. J Virol 1997; 71:1583-1590
14. Nava VE, Rosen A, Veliuona MA, Clem RJ, Levine B, Hardwick JM. Sindbis virus induces apoptosis through a caspase-dependent, CrmA-sensitive pathway. J Virol 1998; 72:452-459 (Pubitemid 28048858)
15. Lin KI, Pasinelli P, Brown RH, Hardwick JM, Ratan RR. Decreased intracellular superoxide levels activate Sindbis virus-induced apoptosis. J Biol Chem 1999; 274:13650-13655 (Pubitemid 129518584)
16. Burkhart BA, Alcorta DA, Chiao C, Isaacs JS, Barrett JC. Two posttranscriptional pathways that regulate p21(Cip1/Waf1/Sdi1) are identified by HPV16-E6 interaction and correlate with life span and cellular senescence. Exp Cell Res 1999; 247:168-175 (Pubitemid 29393973)
17. Marechal V, Piolot T. Lytic infection by double-strand DNA viruses and cell cycle alterations. Pathol Biol (Paris) 2000; 48:289-300. (Pubitemid 30318129)
18. Nishizawa M, Kamata M, Katsumata R, Aida Y. A carboxy-terminally truncated form of the human immunodeficiency virus type 1 Vpr protein induces apoptosis via G(1) cell cycle arrest. J Virol 2000; 74:6058-6067
19. Yuan X, Shan Y, Zhao Z, Chen J, Cong Y. G0/G1 arrest and apoptosis induced by SARS-CoV 3b protein in transfected cells. Virol J 2005; 2:66. (Pubitemid 41215515)
20. Giannoudis A, Herrington CS. Differential expression of p53 and p21 in low grade cervical squamous intraepithelial lesions infected with low, intermediate and high risk human papillomaviruses. Cancer 2000; 89:1300-1307 (Pubitemid 30707449)
21. Bissonnette N, Hunting DJ. p21-induced cycle arrest in G1 protects cells from apoptosis induced by UV-irradiation or RNA polymerase II blockage. Oncogene 1998; 16:3461-3469 (Pubitemid 28349689)
22. Tian H, Wittmack EK, Jorgensen TJ. p21WAF1/CIP1 antisense therapy radiosensitizes human colon cancer by converting growth arrest to apoptosis. Cancer Res 2000; 60:679-684 (Pubitemid 30094567)
23. Mahyar-Roemer M, Roemer K. p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents. Oncogene 2001; 20:3387-3398 (Pubitemid 32588987)
24. Wen JS, Zhao WZ, Liu JW, Zhou H, Tao JP, Yan HJ, et al. Genomic analysis of a Chinese isolate of Getahlike virus and its phylogenetic relationship with other Alphaviruses. Virus Genes 2007; 35:597-603. (Pubitemid 350012751)
25. Brown CM, Timoney PJ. Getah virus infection of Indian horses. Trop Anim Health Prod 1998; 30:241-252
26. Waldman T, Lengauer C, Kinzler KW, Vogelstein B. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 1996; 381:713-716 (Pubitemid 26196573)
27. Garner E, Martinon F, Tschopp J, Beard P, Raj K. Cells with defective p53-p21-pRb pathway are susceptible to apoptosis induced by p84N5 via caspase-6. Cancer Res 2007; 67:7631-7637 (Pubitemid 47281355)
28. Garner E, Raj K. Protective mechanisms of p53-p21-pRb proteins against DNA damage-induced cell death. Cell Cycle 2008; 7:277-282
29. Tsurimoto T, Melendy T, Stillman B. Sequential initiation of lagging and leading strand synthesis by two different polymerase complexes at the SV40 DNA replication origin. Nature 1990; 346:534-539 (Pubitemid 20238801)
30. Newlon CS. Putting it all together: building a prereplicative complex. Cell 1997; 91:717-720 (Pubitemid 28007728)
31. Xie J, Li Y, Huang Y, Qiu P, Shu M, Zhu W, et al. Anesthetic pentobarbital inhibits proliferation and migration of malignant glioma cells. Cancer Lett 2009.
32. Dai Y, Hamm TE, Dent P, Grant S. Cyclin D1 overexpression increases the susceptibility of human U266 myeloma cells to CDK inhibitors through a process involving p130-, p107- and E2F-dependent S phase entry. Cell Cycle 2006; 5:437-446
33. Aprelikova O, Xiong Y, Liu ET. Both p16 and p21 families of cyclin-dependent kinase (CDK) inhibitors block the phosphorylation of cyclin-dependent kinases by the CDK-activating kinase. J Biol Chem 1995; 270:18195-18197
34. Abbas T, Jha S, Sherman NE, Dutta A. Autocatalytic phosphorylation of CDK2 at the activating Thr160. Cell Cycle 2007; 6:843-852 (Pubitemid 46572627)
35. Rodriguez R, Meuth M. Chk1 and p21 cooperate to prevent apoptosis during DNA replication fork stress. Mol Biol Cell 2006; 17:402-412 (Pubitemid 43049492)
36. Suh EJ, Kim TY, Kim SH. PP2Cgamma-mediated S phase accumulation induced by the proteasome-dependent degradation of p21(WAF1/CIP1). FEBS Lett 2006; 580:6100-6104
37. Kuwajerwala N, Cifuentes E, Gautam S, Menon M, Barrack ER, Reddy GP. Resveratrol induces prostate cancer cell entry into S phase and inhibits DNA synthesis. Cancer Res 2002; 62:2488-2492 (Pubitemid 34462723)
38. Asada M, Yamada T, Ichijo H, Delia D, Miyazono K, Fukumuro K, et al. Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation. EMBO J 1999; 18:1223-1234 (Pubitemid 29110307)
39. Suzuki A, Tsutomi Y, Miura M, Akahane K. Caspase 3 inactivation to suppress Fas-mediated apoptosis: identification of binding domain with p21 and ILP and inactivation machinery by p21. Oncogene 1999; 18:1239-1244 (Pubitemid 29085997)
40. Huang WH, Yung BY, Syu WJ, Lee YH. The nucleolar phosphoprotein B23 interacts with hepatitis delta antigens and modulates the hepatitis delta virus RNA replication. J Biol Chem 2001; 276:25166-25175 (Pubitemid 37412998)
41. Szebeni A, Mehrotra B, Baumann A, Adam SA, Wingfield PT, Olson MO. Nucleolar protein B23 stimulates nuclear import of the HIV-1 Rev protein and NLS-conjugated albumin. Biochemistry 1997; 36:3941-3949 (Pubitemid 27154715)
42. Koyama AH, Fukumori T, Fujita M, Irie H, Adachi A. Physiological significance of apoptosis in animal virus infection. Microbes Infect 2000; 2:1111-1117 (Pubitemid 30664225)
43. Roulston A, Marcellus RC, Branton PE. Viruses and apoptosis. Annu Rev Microbiol 1999; 53:577-628.
44. Barber GN. Host defense, viruses and apoptosis. Cell Death Differ 2001; 8:113-126
45. Levine B, Huang Q, Isaacs JT, Reed JC, Griffin DE, Hardwick JM. Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene. Nature 1993; 361:739-742 (Pubitemid 23070484)
46. Li ML, Stollar V. Alphaviruses and apoptosis. Int Rev Immunol 2004; 23:7-24.
47. Kiiver K, Merits A, Sarand I. Novel vectors expressing anti-apoptotic protein Bcl-2 to study cell death in Semliki Forest virus-infected cells. Virus Res 2008; 131:54-64. (Pubitemid 350235681)
48. Op De Beeck A, Caillet-Fauquet P. The NS1 protein of the autonomous parvovirus minute virus of mice blocks cellular DNA replication: a consequence of lesions to the chromatin? J Virol 1997; 71:5323-5329
49. Saudan P, Vlach J, Beard P. Inhibition of S phase progression by adeno-associated virus Rep78 protein is mediated by hypophosphorylated pRb. EMBO J 2000; 19:4351-4361 (Pubitemid 30623746)
50. Li FQ, Tam JP, Liu DX. Cell cycle arrest and apoptosis induced by the coronavirus infectious bronchitis virus in the absence of p53. Virology 2007; 365:435-445
51. Roninson IB. Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts. Cancer Lett 2002; 179:1-14.
52. 1 restriction point. Crit Rev Oncog 1996; 7:127-142
53. Lu Y, Yamagishi N, Yagi T, Takebe H. Mutated p21(WAF1/CIP1/SDI1) lacking CDK-inhibitory activity fails to prevent apoptosis in human colorectal carcinoma cells. Oncogene 1998; 16:705-712 (Pubitemid 28076081)
54. Matranga CB, Shapiro GI. Selective sensitization of transformed cells to flavopiridol-induced apoptosis following recruitment to S phase. Cancer Res 2002; 62:1707-1717
55. WAF1/CIP1 expression. Biochem Biophys Res Commun 1996; 227:564-569
56. Nakanishi Y, Pei XH, Takayama K, Bai F, Izumi M, Kimotsuki K, et al. Polycyclic aromatic hydrocarbon carcinogens increase ubiquitination of p21 protein after the stabilization of p53 and the expression of p21. Am J Respir Cell Mol Biol 2000; 22:747-754 (Pubitemid 30400255)
57. Cip1 ubiquitination. Mol Cell 2000; 5:403-410
58. Oh H, Mammucari C, Nenci A, Cabodi S, Cohen SN, Dotto GP. Negative regulation of cell growth and differentiation by TSG101 through association with p21(Cip1/WAF1). Proc Natl Acad Sci USA 2002; 99:5430-5435 (Pubitemid 34411565)
59. Jascur T, Brickner H, Salles-Passador I, Barbier V, El Khissiin A, Smith B, et al. Regulation of p21(WAF1/ CIP1) stability by WISp39, a Hsp90 binding TPR protein. Mol Cell 2005; 17:237-249 (Pubitemid 40138618)
60. Carmo-Fonseca M, Mendes-Soares L, Campos I. To be or not to be in the nucleolus. Nat Cell Biol 2000; 2:107-112
61. Olson MO, Dundr M, Szebeni A. The nucleolus: an old factory with unexpected capabilities. Trends Cell Biol 2000; 10:189-196 (Pubitemid 30193267)
62. Andersen JS, Lam YW, Leung AK, Ong SE, Lyon CE, Lamond AI, et al. Nucleolar proteome dynamics. Nature 2005; 433:77-83.
63. Richardson WD, Mills AD, Dilworth SM, Laskey RA, Dingwall C. Nuclear protein migration involves two steps: rapid binding at the nuclear envelope followed by slower translocation through nuclear pores. Cell 1988; 52:655-664 (Pubitemid 18078643)
64. Szebeni A, Olson MO. Nucleolar protein B23 has molecular chaperone activities. Protein Sci 1999; 8:905-912 (Pubitemid 29165421)
65. Sipos K, Olson MO. Nucleolin promotes secondary structure in ribosomal RNA. Biochem Biophys Res Commun 1991; 177:673-678
66. Borer RA, Lehner CF, Eppenberger HM, Nigg EA. Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell 1989; 56:379-390
67. Stegh AH, Schickling O, Ehret A, Scaffidi C, Peterhansel C, Hofmann TG, et al. DEDD, a novel death effector domain-containing protein, targeted to the nucleolus. EMBO J 1998; 17:5974-5986 (Pubitemid 28474791)
68. Kubota S, Siomi H, Satoh T, Endo S, Maki M, Hatanaka M. Functional similarity of HIV-I rev and HTLV-I rex proteins: identification of a new nucleolartargeting signal in rev protein. Biochem Biophys Res Commun 1989; 162:963-970 (Pubitemid 19214678)
69. Zhang Y, Xiong Y. Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53. Mol Cell 1999; 3:579-591 (Pubitemid 29268441)
70. WAF1/CIP1 and contributes to its stability. Cell Cycle 2009; 8:889-895
71. Stauber RH, Pavlakis GN. Intracellular trafficking and interactions of the HIV-1 Tat protein. Virology 1998; 252:126-136 (Pubitemid 28564139)
72. Tamm K, Merits A, Sarand I. Mutations in the nuclear localization signal of nsP2 influencing RNA synthesis, protein expression and cytotoxicity of Semliki Forest virus. J Gen Virol 2008; 89:676-686
73. Jakob R. Nucleolar accumulation of Semliki Forest virus nucleocapsid C protein: influence of metabolic status, cytoskeleton and receptors. J Med Microbiol 1994; 40:389-392 (Pubitemid 24205151)
74. Favre D, Studer E, Michel MR. Two nucleolar targeting signals present in the N-terminal part of Semliki Forest virus capsid protein. Arch Virol 1994; 137:149-155 (Pubitemid 2115958)
75. Nolan L, Johnson PW, Ganesan A, Packham G, Crabb SJ. Will histone deacetylase inhibitors require combination with other agents to fulfil their therapeutic potential? Br J Cancer 2008; 99:689-694
76. Janicke RU, Sohn D, Essmann F, Schulze-Osthoff K. The multiple battles fought by anti-apoptotic p21. Cell Cycle 2007; 6:407-413 (Pubitemid 46393442)
77. Blagosklonny MV. Are p27 and p21 cytoplasmic oncoproteins? Cell Cycle 2002; 1:391-393
78. Gorospe M, Cirielli C, Wang X, Seth P, Capogrossi MC, Holbrook NJ. p21(Waf1/Cip1) protects against p53-mediated apoptosis of human melanoma cells. Oncogene 1997; 14:929-935 (Pubitemid 27122425)
79. Waldman T, Zhang Y, Dillehay L, Yu J, Kinzler K, Vogelstein B, et al. Cell cycle arrest versus cell death in cancer therapy. Nat Med 1997; 3:1034-1036 (Pubitemid 27391962)